batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. German Merck plays hardball to get SpringWorks 28 April 2025 No ASCO glory for Caribou 25 April 2025 Akeso cracks the US at last 25 April 2025 Add head and neck cancer to ALX's failures 25 April 2025 Sanofi cools on Innate again 23 April 2025 HengRui challenges with a Polivy follow-on 22 April 2025 First-line breast cancer is in Enhertu’s Destiny 22 April 2025 Merck and Daiichi look for more ifinatamab white space 22 April 2025 Load More